Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data publish...
Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, fur...
SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance") today announced that the National ...
Statistically significant improvements in lung function Consistent trends of quality of life and exa...
Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD...
* Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne partic...
SHANGHAI, Sept. 11, 2024 /PRNewswire/ -- Nuance Pharma today announced it has completed the recruit...
SHANGHAI, June 27, 2024 /PRNewswire/ -- Nuance Pharma's global partner Verona Pharma plc (Nasdaq: V...
SHANGHAI, June 28, 2023 /PRNewswire/ -- Nuance Pharma announces its partner, Verona Pharma plc (Nas...
* Bentrio® meets primary efficacy endpoint in NASAR clinical trial in seasonal allergic rhinitis ...
SHANGHAI, April 6, 2023 /PRNewswire/ -- Nuance Pharma ("the Company") announces dosing of first pat...
SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces partnership with DK...
SHANGHAI, Nov. 13, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug...
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug...
* All 16 healthy normal volunteers (HNVs) were dosed and no serious adverse event was reported ...